OMS103HP
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for OMS103HP, covering 2011-06-27 to 2012-10-12. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of OMS103HP in Patients Undergoing Allograft Anterior Cruciate Ligament (ACL) Reconstruction [Phase 3]